The company reached profitability in 2025 and

该公司在2025年实现盈利，并且

is projected to generate $500 million in gross healthcare system savings while tripling its patient base from 2024 through the end of 2026.

预计将在2024年至2026年底期间，使患者基数增长两倍，并为医疗系统带来5亿美元的总节约成本。

NEW YORK

纽约

,

，

July 8, 2026

2026年7月8日

/PRNewswire/ --

/美通社/ --

Pearl Health

珍珠健康

, a healthcare technology company helping manage risk and deliver better care to Medicare patients, today announced a $110 million capital raise, comprised of equity investment led by Andreessen Horowitz with participation from Viking Global Investors, AlleyCorp, Ulysses Capital, and a debt facility led by Trinity Capital.

一家帮助管理风险并为医疗保险患者提供更优质护理的医疗科技公司今天宣布完成1.1亿美元融资，其中包括由Andreessen Horowitz领投、Viking Global Investors、AlleyCorp、Ulysses Capital参与的股权投资，以及由Trinity Capital牵头的债务融资。

The new capital will expand Pearl's AI platform, turning clinical intelligence into measurable outcomes, and accelerate its growth across enterprise health system and payer partnerships, its expansion into Medicare Advantage, and new risk offerings..

新资本将助力Pearl拓展其人工智能平台，将临床智能转化为可衡量的成果，并加速其在企业级医疗系统与支付方合作伙伴关系中的增长、在Medicare Advantage（联邦医疗保险优势计划）领域的扩张，以及推出新的风险保障产品。

More than 70 million people today rely on Medicare, with costs exceeding $1 trillion and climbing. Across healthcare, reimbursement is increasingly tied to outcomes rather than utilization, creating powerful incentives for providers to prevent avoidable illness, intervene earlier, and manage patient populations.

如今，超过7,000万人依赖联邦医疗保险（Medicare），其成本已超过1万亿美元且持续攀升。在整个医疗保健领域，报销机制正日益与治疗效果而非服务使用量挂钩，从而为医疗服务提供者创造了强有力的激励，促使其预防可避免的疾病、更早进行干预并管理患者群体。

As healthcare shifts from reactive treatment to preventative care, demand is accelerating for technologies that enable providers to succeed in this new model..

随着医疗保健从被动治疗转向预防性护理，市场对能够帮助医疗服务提供者在这一新模式中取得成功的技术的需求正在加速增长。

'Pearl was founded on a simple belief: healthcare should reward keeping people healthy, not just treating them when they are sick,' said Michael Kopko, co-founder and CEO of Pearl Health. 'Unnecessary costs and poor outcomes persist in US healthcare because most providers lack the capabilities to shift to outcomes-based care alone.

“Pearl 的创立基于一个简单的信念：医疗保健体系应奖励保持人们健康，而不仅仅是在人们生病时进行治疗。”Pearl Health 联合创始人兼首席执行官 Michael Kopko 表示。“由于大多数医疗服务提供者缺乏独自转向以结果为导向的医疗模式的能力，美国医疗保健体系中不必要的成本和不良结果依然普遍存在。

With this financing, we are investing in accelerated innovation and growth to expand our impact across the healthcare system.'.

“通过此次融资，我们将投资于加速创新和增长，以扩大我们在整个医疗保健系统的影响力。”

'Pearl has demonstrated that managing risk across large patient populations across many different settings of care can improve patient outcomes, generate meaningful savings, and support a sustainable business model at scale,' said Vineeta Agarwala, MD, general partner at Andreessen Horowitz. 'Pearl's ability to enable providers to participate in value-based payment p'rograms successfully – and to do so through technology, rather than clinical workforce expansion – is a testament to both the vision and execution of the Pearl team.'.

“Pearl 已经证明，在多种不同护理场景中管理大规模患者群体的风险，可以改善患者预后，产生显著的节约效应，并支持可持续的规模化商业模式。”安德森·霍洛维茨基金（Andreessen Horowitz）普通合伙人 Vineeta Agarwala 医学博士表示。“Pearl 能够通过技术而非扩充临床人力，使医疗服务提供者成功参与基于价值的支付计划，这充分证明了 Pearl 团队的远见与执行力。”

'We believe Pearl Health is changing how providers participate in value-based care, simplifying the data and daily workflow so they can spend more of their time and attention on their patients,' said Phil Gager, Senior Managing Director, Tech Lending at Trinity Capital. 'We are proud to support this team and what they are building as they enter their next stage of growth.'.

“我们相信，Pearl Health 正在改变医疗服务提供者参与价值导向型医疗的方式，通过简化数据和日常工作流程，让他们能够将更多的时间和精力投入到患者身上，” Trinity Capital 科技贷款部门高级董事总经理 Phil Gager 表示。“我们很自豪能够支持这个团队以及他们在进入下一个增长阶段时所构建的事业。”

Pearl's AI platform helps providers across the country manage and predict risk, orchestrate workflows, and automate action before issues become costly emergencies. Pearl's continued expansion of Performance Intelligence will empower population health leaders and care teams with AI-driven, chat-enabled expertise focused on their unique patients and opportunities - delivering real-time insights on total cost of care, quality, and utilization patterns to surface the highest-impact actions.

Pearl 的人工智能平台帮助全国各地的医疗服务提供者管理和预测风险、协调工作流程，并在问题演变为代价高昂的紧急情况之前自动采取行动。Pearl 持续扩展其“绩效智能”（Performance Intelligence）产品，将以人工智能驱动、支持聊天交互的专业能力赋能人群健康领导者和护理团队，这些能力专注于患者个体特征及独特机遇，实时提供关于总体医疗成本、质量和利用模式的洞察，从而凸显最具影响力的行动举措。

Pearl is also advancing development of Care Orchestration AI agents to further automate administrative workflows such as annual wellness visit scheduling, post-discharge follow-ups, and care management outreach, freeing clinicians to spend more time on patient care..

Pearl 还在推进护理协调 AI 智能体的开发，以进一步自动化年度健康访视预约、出院后随访以及护理管理外联等行政工作流程，从而让临床医生能够将更多时间投入到患者护理中。

Pearl supports a network of more than 10,000 providers, including health systems like University of Vermont Health and MDX Hawaii, across over 40 states, caring for over 250,000 Medicare beneficiaries. The company manages approximately $3.6 billion in annualized medical spend, up from $2.4 billion the prior year and $1.6 billion the year before that.

Pearl 支持一个由超过 10,000 名提供者组成的网络，其中包括佛蒙特大学健康系统（University of Vermont Health）和 MDX Hawaii 等医疗系统，覆盖美国 40 多个州，为超过 25 万名 Medicare（联邦医疗保险）受益人提供护理。该公司管理的年化医疗支出约为 36 亿美元，高于前一年的 24 亿美元以及再前一年的 16 亿美元。

Pearl is projected to deliver $500 million in gross savings and triple its patient base from 2024 through the end of 2026. The company reached profitability in 2025 – a milestone few in this space have achieved while maintaining aggressive growth. .

Pearl 预计在 2024 年至 2026 年底期间实现 5 亿美元的总储蓄，并将其患者基数扩大两倍。该公司于 2025 年实现盈利——在保持强劲增长的同时达成这一里程碑的企业在该领域寥寥无几。

The new raise includes a $50 million equity round and a $60 million credit facility, which will power the next phase of the company's growth, bringing its intelligent risk management model to more providers, more patients, and new segments of the Medicare market.

本轮新融资包括5000万美元的股权融资和6000万美元的信贷额度，将为公司下一阶段的成长提供动力，将其智能风险管理模型拓展至更多的医疗服务提供方、更多的患者以及医疗保险（Medicare）市场的新细分领域。

About Pearl Health

关于 Pearl Health

Pearl Health

珍珠健康

enables clinicians and care organizations to deliver smarter, more affordable care outcomes through AI-powered predictive insights, financial risk modeling, and streamlined workflows. The company is building the platform for healthcare outcomes, identifying at-risk patients so providers can intervene before issues become emergencies.

通过人工智能驱动的预测洞察、财务风险建模和简化的工作流程，帮助临床医生和护理机构提供更智能、更具成本效益的护理成果。该公司正在构建一个医疗成果平台，识别高风险患者，以便医疗服务提供者能够在问题演变为紧急情况之前进行干预。

Founded in 2020, Pearl supports a network of over 10,000 providers and leading health systems across more than 40 states. Learn more at .

Pearl 成立于 2020 年，支持一个由遍布 40 多个州的 10,000 多家医疗服务提供者和领先医疗系统组成的网络。了解更多详情，请访问 。

pearlhealth.com

pearlhealth.com

.

。

About Andreessen Horowitz (a16z)

关于安德森·霍洛维茨基金（a16z）

a16z

a16z

invests in seed to venture to growth-stage technology companies across AI, bio + healthcare, consumer,

投资于人工智能、生物+医疗健康和消费领域的种子期至成长期科技公司，

crypto

加密货币

, enterprise,

, 企业,

fintech

金融科技

, games, infrastructure, and companies building toward American dynamism. We believe the future belongs to builders, and our job is to make sure they have what they need to build it.

、游戏、基础设施以及致力于推动美国活力的企业。我们相信，未来属于建设者，而我们的职责是确保他们拥有实现这一未来所需的一切资源。

About Trinity Capital Inc.

关于 Trinity Capital Inc.

Trinity Capital Inc.

特里尼蒂资本公司

(Nasdaq:

（纳斯达克：

TRIN

三一

) is an international alternative asset manager that seeks to deliver consistent returns for investors through access to private credit markets. Trinity Capital sources and structures investments in well-capitalized growth-oriented companies across five distinct lending verticals: Sponsor Finance, Equipment Finance, Tech Lending, Asset Based Lending, and Healthcare & Life Sciences.

）是一家国际另类资产管理公司，旨在通过进入私人信贷市场为投资者提供稳定的回报。Trinity Capital 在五个不同的贷款领域寻找并构建对资本充足、以增长为导向的公司的投资：赞助金融、设备融资、科技贷款、资产支持贷款以及医疗保健与生命科学。

As a long-term, trusted partner for innovative companies seeking tailored debt solutions, Trinity Capital has deployed more than $5.7 billion across over 470 investments since inception in 2008 (as of March 31, 2026). Headquartered in Phoenix, Arizona, Trinity Capital's dedicated team is strategically located across the United States and Europe.

作为寻求定制债务解决方案的创新型企业的长期可信赖合作伙伴，Trinity Capital 自2008年成立以来（截至2026年3月31日），已在超过470项投资中部署了逾57亿美元的资金。Trinity Capital 总部位于亚利桑那州凤凰城，其专业团队在美国和欧洲各地进行战略性布局。

For more information on Trinity Capital, please visit trinitycapital.com and stay connected to the latest activity via .

如需了解更多关于Trinity Capital的信息，请访问trinitycapital.com，并通过关注最新动态。

LinkedIn

领英

.

。

Notifications

通知

These Materials contain forward-looking statements that relate to, without limitation, future financial performance, business strategy, projected growth, market opportunities, operational plans, anticipated regulatory developments, competitive position, and other similar matters. These statements can generally be identified by the use of forward-looking terminology such as 'may,' 'will,' 'expect,' 'intend,' 'estimate,' 'anticipate,' 'believe,' 'continue,' 'seek,' 'project,' 'plan,' 'potential,' 'preliminary,' 'possible,' or similar expressions.

本材料包含前瞻性陈述，涉及（但不限于）未来财务表现、业务战略、预期增长、市场机会、运营计划、预期的监管发展、竞争地位以及其他类似事项。这些陈述通常可以通过使用前瞻性术语来识别，例如“可能”、“将”、“期望”、“打算”、“估计”、“ anticipate ”、“相信”、“继续”、“寻求”、“预测”、“计划”、“潜在”、“初步”、“可能”或类似表述。

Forward-looking statements are based on current expectations, estimates, forecasts, and projections about the business of Pearl Health, Inc. and its affiliates (collectively, 'Pearl'), the healthcare industry, and general economic conditions. These statements are not guarantees of future performance and involve significant risks, uncertainties, and assumptions that are difficult to predict.

前瞻性陈述基于对 Pearl Health, Inc. 及其关联公司（统称“Pearl”）的业务、医疗保健行业以及总体经济状况的当前预期、估计、预测和推断。这些陈述并非对未来表现的保证，且涉及重大风险、不确定性和难以预测的假设。

Financial projections contained in the Materials are inherently uncertain and speculative in nature and should not be relied upon as necessarily being indicative of future results. The assumptions underlying these projections may prove to be inaccurate, and actual results may vary significantly from projected results.

材料中包含的财务预测本质上具有不确定性和推测性，不应被视为必然预示未来结果。这些预测所依据的假设可能被证明是不准确的，实际结果可能与预测结果存在重大差异。

Pearl Health has not independently verified and does not warrant the accuracy or completeness of any third-party data or market research referenced herein..

Pearl Health 未对本文引用的任何第三方数据或市场研究的准确性或完整性进行独立核实，也不对此作出任何保证。

The Materials are for informational purposes only and do not constitute an offer to buy or sell any securities of Pearl.  Any offer or sale of securities will be made only through definitive offering documents, which will contain material information not contained herein and which will supersede these Materials in their entirety.

本材料仅供信息参考，不构成购买或出售Pearl任何证券的要约。任何证券的发售或销售仅将通过最终发行文件进行，该等文件将包含本材料中未载有的重要信息，并完全取代本材料。

The Materials should not be construed as investment, legal, tax, or financial advice. Pearl Health undertakes no obligation to publicly update or revise any forward-looking statements, projections or other aspects of the Materials, whether as a result of new information, future events, changed circumstances, or otherwise, except as may be required by applicable securities laws. .

本材料不应被解读为投资、法律、税务或财务建议。除非适用法律另有要求，Pearl Health 没有义务因新信息、未来事件、情况变化或其他原因而公开更新或修订本材料中的任何前瞻性陈述、预测或其他内容。

Media Contact

媒体联系人

Ksenia Kulik, Interdependence

克谢尼娅·库利克，《相互依存》

(919) 349-3786

(919) 349-3786

[email protected]

[email protected]

SOURCE Pearl Health

来源：Pearl Health

21

二十一

%

百分比

more press release views with

更多新闻稿浏览量，通过

Request a Demo

申请演示